MedTech News
.................... by Andrew Celentano
AI model predicts neural network degeneration patterns in ALS progression
New research from the University of St Andrews, the University of Copenhagen and Drexel University has developed AI computational models that predict the degeneration of neural networks in amyotrophic lateral sclerosis (ALS).
A new robotic system could perform delicate eye surgery
Retinal vein occlusion (RVO) is a severe disease that occurs when a vein in the light-sensitive layer at the back of the eye (i.e., the retina) becomes blocked, which results in a loss of vision. There are currently a few medical interventions that address RVO, including the periodic injection of medications that block the abnormal growth of blood vessels or of steroids, which reduce swelling and inflammation.
Autonomous AI agents developed to detect early signs of cognitive decline
A team of Mass General Brigham researchers has developed one of the first fully autonomous artificial intelligence (AI) systems capable of screening for cognitive impairment using routine clinical documentation.
Amplifi Vascular wins FDA breakthrough nod for vein dilation system
Amplifi Vascular announced that it received breakthrough device designation for its Amplifi Vein Dilation System.
3D hybrid imaging system could address limitations of MRI, CT and ultrasound
In a proof-of-concept study, researchers from the Keck School of Medicine of USC and the California Institute of Technology (Caltech) have shown that an innovative, noninvasive technique can be used to quickly collect 3D images of the human body, from head to foot.
Vascularized retinal organoids engineered with functional light-signal pathways
Until now, it has been difficult to maintain retinal ganglion cells deep inside organoids over extended periods. The supply of nutrients and oxygen in the densely packed tissues is limited, leading to cell death.
Scientists discover natural ‘brake’ that could stop harmful inflammation
Researchers at University College London (UCL) have uncovered a key mechanism that helps the body switch off inflammation—a breakthrough that could lead to new treatments for chronic diseases affecting millions worldwide.
Alternative RNA splicing tied to schizophrenia-like behaviors in animal models
In a new study, Chinese researchers have discovered the previously unrecognized role of alternative splicing of the DOC2A gene in schizophrenia.